Beta3-adrenoreceptor agonist mirabegron - a potential antiobesity drug?
a Institute of Endocrinology , Obesity Management Center , Prague , Czech Republic.
Vojtech
V
Hainer
Brown adipose tissue; energy expenditure; mirabegron; obesity; overactive bladder; β3-adrenoreceptor agonists